0000000000899635
AUTHOR
A Notarbartolo
showing 62 related works from this author
Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study
2004
L’uso di stent con sirolimus e’ significativamente associate alla riduzione della mortalita’ totale e della morbidita’ cardiovascolare sia a 6 mesi c…
2006
Saturated and unsaturated free fatty acids (FFA) modulate differently HDL uptake in hepatoma HEPG2 cells
2003
Lipoprotein remnants accumulation in end-stage renal disease: evidence of an active role of heparin administration during hemodialysis
2003
Coronarografia diagnostica e conseguenti scelte terapeutiche dopo l’avvento degli stent alla rapamicina: approccio attuale ed evoluzione degli ultimi…
2003
Variations in plasma lipids and in the LDL peak particle size after acute myocardial infarction
2002
Livelli ridotti di cistatina C nell’infarto miocardico acuto vs. angina instabile, aneurisma aortico e controlli normali
2001
Clinical predictors of adverse events in a 1 year follow-up study post-PCI
2003
Chilomicronemia transitoria causa di diabete di tipo I in assenza di markers umorali di autoimmunità in una bambina di nove anni
2001
La simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura: effetti delle statine “beyond-cholesterol”
2002
Il polimorfismo genico CD14 C(-260)>T non e’ un fattore di rischio per infarto miocardico acuto
2002
Treatment of primary hypercholesterolemia: comparison of the effectiveness of different statins
2000
Use of stents with sirolimus is significantly associated with a reduction in mortality and cardiovascular morbidity at 6- and 12-months post-PTCA
2006
Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events post-PTCA: a 1 year follow-up study
2004
Prevalenza di fattori di rischio e variazione temporale dei parametri lipidici in una serie consecutiva di 350 infarti acuti del miocardio registrati…
2001
Effects of dialysis on the cardiovascular risk of uremic patients: increase in levels of remnant particles
2002
La simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura: effetti delle statine “beyond-cholesterol”
2002
Low-density-lipoprotein peak particle size in a Mediterranean population.
2003
Background: The predominance of small, dense low-density lipoprotein (LDL) particles ('LDL phenotype B') has been associated with a three-fold increased risk of myocardial infarction, but the feasibility of the identification of small, dense LDL as independent predictors of coronary artery disease risk in population studies remains questioned. Design: We evaluated the LDL peak particle size and its relation with other established risk factors for coronary heart disease in a group of 156 randomized subjects living on the Mediterranean island of Ustica (71 males and 85 women, range of age 20-69 years), representing approximately 30% of the total population. Results: The prevalence of LDL phen…
Risultati del follow-up di 6 mesi in 100 pazienti con stent medicato con rapamicina rispetto ad altri 100 con stent tradizionale
2004
Changes in levels of triglyceride-rich lipoprotein subfractions during dialysis in uremic patients
2002
Coronarografia diagnostica: evoluzione temporale in relazione ai progressi della PTCA
2002
CD14 C(-260)>T gene polymorphism is not a risk factor for myocardial infarction
2002
Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
2005
Triglycerides (TGs) are vehicled by multiple particles with different abilities to promote atherosclerosis. Among plasma TG-rich lipoproteins (TRLs), subspecies may or may not contain apolipoprotein E (apoE) molecules: in this study, we evaluated the relative contribution of apoE-rich and apoE-poor TRLs to coronary atherosclerosis. We selected a group of males with premature coronary artery disease (CAD) without any of the classical nonlipid risk factors and/or high plasma lipid levels and evaluated the plasma concentration of TRL subspecies in comparison with healthy controls. Patients with CAD and controls had total cholesterol and TG levels within the normal range (despite slightly, even…
Relazione tra il size delle LDL e l’estensione della malattia vasale coronarica in 72 pazienti maschi sottoposti a coronarografia diagnostica
2005
Descrizione di una famiglia siciliana con iper-alfa-lipoproteinemia con deficit di CETP
2002
Accumulation of ApoE-containing triglyceride-rich lipoproteins in normolipidemic men with premature coronary artery disease
2000
Studio epidemiologico “Ustica”: bassa prevalenza delle LDL aterogene in una popolazione mediterranea
2002
ApoE polymorphism in a small Mediterranean island: Relationships with plasma lipids, lipoproteins and LDL particle size
2001
Polymorphisms of apoE gene are able to modulate lipoprotein metabolism at different steps and to influence LDL-cholesterol (LDL-C) levels and also other lipoproteins features. Population studies documented large differences in the frequency of apoE alleles which could be even related to the prevalence of cardiovascular disease. In this study we evaluated the apoE genotypes and allele frequency in 576 subjects living in a small island in the Tyrrhenian Sea and the relative contribution of apoE polymorphism on plasma lipid and lipoprotein profile, including LDL particle size. We found a cumulative frequency of 0.073, 0.866 and 0.061 for ε2, ε3 and ε4 alleles respectively. Moreover ε3 subjects…
Il diabete, la familiarita’ per malattie cardiovascolari e l’estensione della malattia vasale quali predittori degli eventi clinici ad 1 anno di foll…
2004
Description of a sicilian family with hyper-alpha-lipoproteinemia with deficit of CETP activity
2002
Uso degli stent medicati con rapamicina in pazienti con situazioni anatomiche o cliniche che favoriscono la restenosi: risultati del follow-up di 6 m…
2004
Nonalcoholic fatty liver and metabolic syndrome in Italy: Results from a multicentric study of the Italian Arteriosclerosis society
2013
Nonalcoholic fatty liver disease (NAFLD) is associated with all the components of metabolic syndrome (MS) and might to be considered an additional component of MS itself. The Italian Society for the Study of Atherosclerosis (SISA) in 2005 started a research project aimed to study the NAFLD, using ultrasound (US), in nondiabetic MS subjects matching at least one of the ATP III criteria for HDL-C or triglycerides [TG]. Prevalence of US-NAFLD and its associated risk factors and prevalence of hypertransaminasemia and its possible determinants were evaluated. NAFLD prevalence was 0.78. Men with steatosis compared to men without steatosis were younger (P < 0.05) with higher TG (P < 0.03), homeost…
LDL peak particle size and the extension of coronary atherosclerosis in 72 patients that underwent an angiographic exam
2004
Effetti della dialisi sul rischio cardiovascolare nei pazienti uremici: aumento delle particelle remnants
2009
Le variazioni dei valori dell’assetto lipidico durante la risposta di fase acuta post-infarto miocardico acuto sono accompagnate da modifiche nel siz…
2001
Dati del follow-up di 6 mesi sui primi 100 pazienti con stent medicati con rapamicina, con situazioni anatomiche e cliniche favorenti la restenosi
2004
LDL size, density and receptor affinity variation during an oral load in mild hyper-triglyceridemic and normal subjects
2003
Fibrinogen as predictor of mortality in a 42-months follow-up after acute myocardial infarction
2002
Il polimorfismo genico del CD14 C(-260)>T non e’ un fattore di rischio per infarto miocardico acuto
2002
Levels of b-sitosterol in a sicilian sample of hyper-cholesterolemic patients
2002
Low prevalence of the atherogenic small, dense LDL in a mediterranean population. Nutrition, Metabolism and Cardiovascular Diseases
2002
Accumulo di particelle aterogene remnants dopo la dialisi in pazienti uremici
2002
Dati di mortalita’ e morbilita’ del follow-up condotto su 123 pazienti sottoposti ad angioplastica coronarica
2001
Clinical predictors of adverse events in a 1 year follow-up study post-PTCA.
2002
Correlazione in 309 pazienti coronaropatici tra i livelli di HDL-colesterolo e l’estensione della coronaropatia
2001
Cystatin C levels are decreased in acute myocardial infarction: Effect of cystatin C G73A gene polymorphism on plasma levels
2005
Background: Cystatin C is the most abundant protease inhibitor in the plasma. Low plasma levels have been found in patients with aortic aneurysms and they seem correlated with the extension of the aortic lesions in early aneurysms detected by ultrasonography. Methods: In this study, plasma levels of cystatin C have been investigated in patients with acute myocardial infarction (AMI), unstable angina and controls. The effect on plasma levels of the G73A polymorphism of the CST3 gene has been also evaluated. Results: Patients with acute myocardial infarction showed significantly lower levels of cystatin C compared to unstable angina and controls, but levels were nearly normal in a week after …